scholarly journals The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study

Respiration ◽  
2021 ◽  
pp. 1-6
Author(s):  
Catharina C. Moor ◽  
Nelleke C. Tak van Jaarsveld ◽  
Catherine Owusuaa ◽  
Jelle R. Miedema ◽  
Sara Baart ◽  
...  

<b><i>Background:</i></b> Idiopathic pulmonary fibrosis (IPF) is a progressive fatal disease with a heterogeneous disease course. Timely initiation of palliative care is often lacking. The surprise question “Would you be surprised if this patient died within the next year?” is increasingly used as a clinical prognostic tool in chronic diseases but has never been evaluated in IPF. <b><i>Objective:</i></b> We aimed to evaluate the predictive value of the surprise question for 1-year mortality in IPF. <b><i>Methods:</i></b> In this prospective cohort study, clinicians answered the surprise question for each included patient. Clinical parameters and mortality data were collected. The sensitivity, specificity, accuracy, negative, and positive predictive value of the surprise question with regard to 1-year mortality were calculated. Multivariable logistic regression analysis was performed to evaluate which factors were associated with mortality. In addition, discriminative performance of the surprise question was assessed using the C-statistic. <b><i>Results:</i></b> In total, 140 patients were included. One-year all-cause mortality was 20% (<i>n</i> = 28). Clinicians identified patients with a survival of &#x3c;1 year with a sensitivity of 68%, a specificity of 82%, an accuracy of 79%, a positive predictive value of 49%, and a negative predictive value of 91%. The surprise question significantly predicted 1-year mortality in a multivariable model (OR 3.69; 95% CI 1.24–11.02; <i>p</i> = 0.019). The C-statistic of the surprise question to predict mortality was 0.75 (95% CI 0.66–0.85). <b><i>Conclusions:</i></b> The answer on the surprise question can accurately predict 1-year mortality in IPF. Hence, this simple tool may enable timely focus on palliative care for patients with IPF.

2017 ◽  
Vol 32 (2) ◽  
pp. 535-542 ◽  
Author(s):  
Kimberley Burke ◽  
Lucy Helen Coombes ◽  
Antoinette Menezes ◽  
Anna-Karenia Anderson

2016 ◽  
Vol 116 (08) ◽  
pp. 396-396

In the Original Article “The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study” (Thromb Haemost 2016; 115: 1101-1108) by Palareti et al. the last sentence at the end of the second paragraph on page 1105 of the article is wrong and should read as follows: “Regarding the ability of the score ≥2 to predict a TTR <65%, the C statistic was 0.52 (95% CI 0.48–0.55; p = 0.35); the sensitivity was 74% (70.4–77.8), specificity 29% (25.3–33.2), negative predictive value 52% (95% CI 45.8–57.7) and positive predictive value 53% (40.0–56.2).” The authors apologise for this error.


Eye ◽  
2021 ◽  
Author(s):  
Livia Faes ◽  
Meriam Islam ◽  
Lucas M. Bachmann ◽  
Kenny R. Lienhard ◽  
Martin K. Schmid ◽  
...  

Abstract Background Home monitoring of hyperacuity allows early detection of progression in exudative neovascular age-related macular degeneration (nvAMD) and diabetic macular oedema (DMO). However, false alarms may pose a significant burden to both patients and healthcare professionals alike. Purpose To assess the false alarm rate and positive predictive value of smartphone-based home monitoring of nvAMD and DMO. Methods Patients treated with anti-angiogenic therapy in a pro re nata scheme for nvAMD or DMO at the Medical Retina service (Lucerne, Switzerland) between March and June 2016 were included in this prospective cohort study. The home monitoring test Alleye (Oculocare Ltd, Switzerland) provided a session score from 0–100 in addition to a traffic-light system feedback via the smartphone application. Three consecutive “red” scores were considered as a positive test or alarm signal. Specificity, 1-specificity (false alarm rate) and the predictive value for optical coherence tomography-based disease progression were analysed. Results 73 eyes of 56 patients performed 2258 tests in 222 “follow-up periods”. Progression was observed in 141 periods (63.5%). The specificity of the test was 93.8% (95% CI: 86.2–98.0%), the false alarm rate 6.1% (95% CI: 2.0–13.8%), and the positive predictive value 80.0% (95% CI: 59.3–93.2%) for the detection of progression. Conclusion False alarm rates for the detection of progression in macular disease via home monitoring is low. These findings suggest that home monitoring may be a useful adjunct for remote management of nvAMD and DMO.


Sign in / Sign up

Export Citation Format

Share Document